Blogs

Be the first person to recommend this.
A new ToxChats© podcast episode, Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern , is now available to stream online. This episode of ToxChats is designed to offer listeners a practical and insightful overview of the waiver process for carcinogenicity studies in pharmaceutical development, with a focus on the ICH S1B and S1B(R1) guidance documents. In this episode, host Zac Iloyd engages with two recognized experts to explore critical considerations for obtaining waivers, discuss the characteristics of strong versus weak waiver requests, and share real-world strategies for leveraging the weight of evidence ...
0 comments
Be the first person to recommend this.
#EducationCourse #AdvCompTox
0 comments
Be the first person to recommend this.
#Sessions #SessionProposals #actox2027
0 comments
Be the first person to recommend this.
Register for the Annual Meeting #actox2026 #Plenary
0 comments
Be the first person to recommend this.
#EducationCourse #AdvCompTox
0 comments
Be the first person to recommend this.
#actox2026 #Support #Supporter #2026AnnualMeeting
0 comments
Be the first person to recommend this.
#actox2026 #actox2026 #2026AnnualMeeting #AM26 #Registration
0 comments
Be the first person to recommend this.
#EducationCourse #AdvCompTox
0 comments
Be the first person to recommend this.
0 comments
Be the first person to recommend this.
#Education #ACTCourse
0 comments
Be the first person to recommend this.
#eLearning #DiscoveryTox
0 comments
Be the first person to recommend this.
2026 ACT Abstract Submission System is Open! We’re excited to invite you to submit your abstract for the 2026 ACT Annual Meeting! All abstracts must be submitted online by Monday, June 1, 2026 (11:59 pm ET) —so don’t miss this opportunity to share your research with the toxicology community! If you're submitting for the first time, you'll need to create an account. Once you’re set up, simply follow the easy on-screen prompts to complete your submission. Be sure to review the poster guidelines before finalizing. Key Dates: Abstract Acceptance Notifications: Sent via email during the week of July 20, 2026 Registration Deadline for Accepted ...
0 comments
Be the first person to recommend this.
#EducationCourse #AdvCompTox
0 comments
Be the first person to recommend this.
#eLearning #OnlineEducation #OnDemand
0 comments
Be the first person to recommend this.
International Journal of Toxicology ( IJT ), the official journal of the American College of Toxicology, is seeking manuscript submissions in the following (and related) topics: Pharmaceutical safety assessments New approach methodologies (NAMs) Updates to regulatory guidances Virtual control groups IJT welcomes contributions from authors, reviewers, and Editorial Board members from all backgrounds, and supports aspiring and established toxicology professionals. Each issue of IJT provides an important forum for articles that promote basic toxicology research, as well as those that facilitate and improve toxicology practice. Read IJT's ...
0 comments
Be the first person to recommend this.
#Sponsor #sponsorship #AM26 #actox2026
0 comments
Be the first person to recommend this.
#eLearning #DiscoveryTox
0 comments
Be the first person to recommend this.
A new ToxChats© podcast episode, Next-Gen Toxicology: Inside the Organ Chip Revolution with Dr. Donald Ingber , is now available to stream online. In this episode of ToxChats, hosts Lauren Walker and Sarah Benjamin sit down with the groundbreaking Donald Ingber—visionary scientist, engineer, and Founding Director of the Wyss Institute. Dr. Ingber shares how his unique path through medicine, biology, and design converged to spark breakthroughs such as human Organ Chips—systems that are redefining toxicology, drug development, and disease modeling. Together, they discuss how Organ Chips outperform traditional in vitro and animal models, the promise ...
0 comments
Be the first person to recommend this.
#ACT #Membership #Join
0 comments
Be the first person to recommend this.
#CE #CEcourse #ContinuingEducation
0 comments